Tachykardia nadkomorowa
Epidemiologia

Tachykardia nadkomorowa (SVT) jest powszechną arytmią o częstości występowania szacowanej na 2,25-2,29/1000 osób, z roczną zapadalnością około 35-36/100 000 osobolat. W USA liczba leczonych pacjentów z napadową tachykardią nadkomorową (PSVT) wynosi 1,3-2,1 miliona, z 190 000-310 000 nowych przypadków rocznie, co wskazuje na istotny wzrost zachorowań. SVT występuje częściej u kobiet (stosunek 2:1), szczególnie w przypadku AVNRT, który stanowi około 75% przypadków u kobiet i jest związany z fazą lutealną cyklu miesiączkowego. Choroba dotyka wszystkie grupy wiekowe, ze szczytem zachorowań w wieku 36 lat dla AVRT, 48 lat dla AVNRT i 50 lat dla AT. U dzieci SVT występuje z częstością 1:250-1000, z AVRT jako dominującym typem (75%), a u dorosłych najczęstszą postacią jest AVNRT (50-60%). W populacji z wrodzonymi wadami serca (ACHD) makroarytmie przedsionkowe stanowią 75% tachykardii nadkomorowych, a ryzyko arytmii wzrasta z wiekiem (7% w wieku 20 lat do 38% w wieku 50 lat).

Epidemiologia tachykardii nadkomorowej (SVT)

Tachykardia nadkomorowa (SVT) stanowi powszechną arytmię, dotykającą znaczną część populacji. Szacowana częstość występowania SVT wynosi od 2,25 do 2,29 przypadków na 1000 osób w populacji ogólnej123. Według innych szacunków, częstość występowania może wynosić między 168 a 332 przypadków na 100 000 osób4. Roczna zapadalność (liczba nowych przypadków) wynosi około 35-36 na 100 000 osobolat567.

Nowsze dane z analiz retrospektywnych wskazują na istotny wzrost częstości występowania SVT. Badania opublikowane w Journal of Cardiovascular Electrophysiology sugerują, że leczona chorobowość dla napadowej tachykardii nadkomorowej (PSVT) w USA wynosi 1,3-2,1 miliona osób, z około 190 000-310 000 nowych przypadków rocznie8. Badanie to wykazało ponad dwukrotny wzrost częstości występowania i zapadalności na PSVT w porównaniu do wcześniejszych analiz9.

Rozkład według płci

SVT występuje częściej u kobiet niż u mężczyzn, z wyraźną przewagą płci żeńskiej w stosunku 2:1 we wszystkich grupach wiekowych1011. W niektórych badaniach kobiety stanowiły nawet 67,5% wszystkich przypadków SVT12. Ryzyko rozwoju napadowej tachykardii nadkomorowej jest dwukrotnie wyższe u kobiet niż u mężczyzn1314. Szczególnie w przypadku częstoskurczu nawrotnego węzłowego (AVNRT) widoczna jest wyraźna przewaga u kobiet, stanowiąc około 75% przypadków15.

AVNRT jest skorelowany z niższymi poziomami estrogenu i wyższymi poziomami progesteronu, dlatego występuje częściej w fazie lutealnej cyklu miesiączkowego i rzadziej w czasie ciąży16. Tachykardia nadkomorowa ma tendencję do częstszego występowania u kobiet, szczególnie w okresie ciąży1718.

Rozkład według wieku

SVT może wystąpić w każdym wieku, dotykając zarówno niemowlęta, dzieci, jak i dorosłych1920. Szacuje się, że około połowa pacjentów z SVT jest w wieku 45-64 lat21, a średni wiek występowania wynosi około 45 lat22.

Ryzyko rozwoju SVT zwiększa się wraz z wiekiem, z szacowanym 5-krotnie większym prawdopodobieństwem dotknięcia osób starszych niż młodszych232425. U osób w wieku powyżej 65 lat ryzyko jest ponad pięciokrotnie wyższe niż u osób młodszych26.

Szczyt częstości występowania różnych typów SVT w przypadku kierowania na ablację przypada na różne dekady życia: około 36 lat dla AVRT (tachykardia nawrotna przedsionkowo-komorowa), 48 lat dla AVNRT (tachykardia nawrotna węzłowa) i 50 lat dla AT (tachykardia przedsionkowa)27.

SVT u dzieci

Tachykardia nadkomorowa jest najczęstszą objawową arytmią u niemowląt i dzieci282930. Częstość występowania SVT u dzieci szacuje się na 1 przypadek na 250 do 1000 niemowląt i dzieci31. W badaniu kohortowym obejmującym prawie 2 miliony żywych urodzeń między 2000 a 2008 rokiem, 2021 pacjentów (51,6% płci męskiej, ogólna częstość występowania 1,03/1000) miało SVT, z czego zespół Wolffa-Parkinsona-White’a (WPW) stanowił 16,2% przypadków32.

Ponad jedna trzecia nowych przypadków SVT występuje w pierwszych kilku tygodniach życia, często objawiając się po wielu godzinach objawami niewydolności serca33. 50-60% przypadków pediatrycznych SVT pojawia się w pierwszym roku życia34.

AVRT (częstoskurcz nawrotny przedsionkowo-komorowy) jest najczęstszym typem SVT u dzieci, występującym w około 75% przypadków35, podczas gdy AVNRT rzadko występuje przed 2 rokiem życia36. U dzieci poniżej 12 roku życia, dodatkowa droga przedsionkowo-komorowa powodująca częstoskurcz nawrotny jest najczęstszą przyczyną tachykardii nadkomorowej37.

Rozkład typów SVT

Wśród typów SVT, częstoskurcz nawrotny węzłowy (AVNRT) jest najczęstszą postacią u dorosłych, stanowiąc około 50-60% wszystkich przypadków SVT383940. AVNRT jest bardziej powszechny u osób w średnim i starszym wieku4142.

Częstoskurcz nawrotny przedsionkowo-komorowy (AVRT) jest drugim najczęstszym typem SVT u dorosłych (około 30% przypadków)43 i najczęstszym u dzieci44. Występowanie AVRT zmniejsza się wraz z wiekiem, od 60% w pierwszej dekadzie życia do 9% po 70 roku życia4546.

Częstość występowania wzoru WPW (Wolffa-Parkinsona-White’a) w zapisach EKG wynosi 0,1-0,3% w populacji ogólnej, chociaż nie wszyscy pacjenci rozwijają SVT474849. W populacji ogólnej, częstość występowania wzoru WPW w EKG waha się od 0,15-0,25%, wzrastając do 0,55% wśród krewnych pierwszego stopnia pacjentów dotkniętych tą chorobą50.

SVT w szczególnych populacjach

SVT u pacjentów z wrodzonymi wadami serca

Dzieci z wrodzonymi wadami serca, takimi jak anomalia Ebsteina zastawki trójdzielnej, są bardziej narażone na częstoskurcz nawrotny przedsionkowo-komorowy51. Również młodzi dorośli, którzy przeszli operację Fontana lub operację tetralogii Fallota, są bardziej narażeni na arytmie przedsionkowe52.

U pacjentów z wrodzonymi wadami serca (ACHD), makroarytmie nawrotne przedsionkowe są najczęstszym (75%) typem tachykardii nadkomorowej, występującym głównie u pacjentów z anomalią Ebsteina, tetralogią Fallota, procedurami Fontana z pojedynczą komorą, przełożeniem wielkich naczyń (TGA) lub ubytkami przegrody międzyprzedsionkowej (ASD)53.

Dwudziestoletnie ryzyko rozwoju arytmii przedsionkowych wśród pacjentów z wrodzonymi wadami serca u dorosłych (ACHD) wynosiło 7% u pacjenta w wieku 20 lat i 38% u pacjenta w wieku 50 lat w badaniu populacyjnym54.

Stany związane z SVT

SVT jest obserwowana nie tylko u zdrowych osób, ale także często u pacjentów z przebytym zawałem mięśnia sercowego, wypadaniem zastawki mitralnej, chorobą reumatyczną serca, zapaleniem osierdzia, zapaleniem płuc, przewlekłą chorobą płuc i aktualnym zatruciem alkoholowym55.

Czynniki, które mogą zwiększać ryzyko SVT, obejmują:5657

  • Choroby serca (choroba wieńcowa, niewydolność serca, choroba mięśnia sercowego lub zastawki)58
  • Choroby płuc
  • Choroby tarczycy
  • Cukrzyca
  • Obturacyjny bezdech senny
  • Palenie tytoniu
  • Nadużywanie narkotyków

Czynniki, które mogą wywoływać napady SVT, obejmują: nadmiar kofeiny, alkohol, niepokój, wysiłek fizyczny lub nagłe ruchy, takie jak schylanie się59. AVNRT może wystąpić spontanicznie lub po prowokacji wysiłkiem fizycznym, kofeiną, alkoholem, beta-agonistami (salbutamol) lub sympatykomimetykami (amfetaminy)60.

Wpływ ekonomiczny SVT

Obecne leczenie PSVT (napadowa tachykardia nadkomorowa) pochłania znaczne zasoby opieki zdrowotnej. Szacuje się, że rocznie wykonuje się około 80 000 ablacji cewnikowych i ponad 150 000 wizyt na oddziałach ratunkowych/przyjęć szpitalnych z powodu PSVT, co stanowi większość z około 3 miliardów dolarów wydawanych rocznie w USA na leczenie PSVT61.

Badania wykazały, że koszty nigdy nie wracają do poziomu wyjściowego, co wskazuje na potrzebę większej liczby opcji leczenia w długoterminowym zarządzaniu PSVT62.

Błędna diagnoza i opóźnienie w rozpoznaniu

Znaczna część pacjentów ma objawy przez dłuższy czas (>1 rok) przed postawieniem diagnozy SVT, a czasami epizody są błędnie diagnozowane jako stany lękowe lub zaburzenia paniki63.

W jednym z badań, 20 pacjentów (42,6%) zostało błędnie zdiagnozowanych jako cierpiący na stany lękowe/ataki paniki przed prawidłowym rozpoznaniem SVT64. SVT może być łatwo błędnie zdiagnozowana jako lęk z powodu kilku czynników, w tym braku EKG i nakładających się objawów65.

Monitorowanie i nadzór nad tachykardią nadkomorową

Podejścia diagnostyczne

Diagnoza SVT może być wyzwaniem ze względu na jej napadowy charakter. Jeśli pacjent ma objawy SVT, lekarz może zalecić rejestrację rytmu serca za pomocą przenośnego monitora serca66. Dostępne są różne opcje diagnostyczne dla pacjentów bez wcześniej zdiagnozowanej tachykardii nadkomorowej, w tym stosowanie urządzeń konsumenckich i zdalne monitorowanie za pomocą urządzeń medycznych67.

SVT jest potwierdzana za pomocą EKG, które pokazuje nieprawidłowy rytm podczas epizodu68. Badanie z 2020 roku opublikowane w Clinical Medicine sugeruje, że stosowanie 12-odprowadzeniowego EKG jest kluczowe w diagnozowaniu SVT i określaniu krótko- i długoterminowego postępowania w tej chorobie69.

Diagnostyka SVT może obejmować:70

  • Elektrokardiogram (EKG)
  • Monitor Holtera
  • Monitor zdarzeń
  • Echokardiogram
  • Wszczepialny rejestrator pętlowy

Monitorowanie w szczególnych populacjach

W badaniu kohortowym dzieci z SVT, do 15 roku życia roczne ryzyko nagłej śmierci wynosiło 0,01% na pacjenta rocznie71. Dzieci z rozpoznaną SVT powinny być regularnie monitorowane przez kardiologa pediatrycznego w celu zapewnienia ciągłej opieki nad SVT72.

Eksperci zalecają, aby lekarze zarządzający pacjentami z ACHD (wrodzone wady serca u dorosłych) obowiązkowo konsultowali się z ekspertami ze względu na małą liczbę pacjentów i potencjalnie zagrażające życiu arytmie73.

Wytyczne kliniczne

Istnieją ustalone wytyczne dotyczące opieki nad pacjentami z SVT, w tym:74

  • Wytyczne ACC/AHA/HRS z 2015 r. dotyczące postępowania z dorosłymi pacjentami z tachykardią nadkomorową
  • Wytyczne ESC z 2019 r. dotyczące postępowania z pacjentami z tachykardią nadkomorową

Wytyczne te stanowią kompleksowy i dobrze napisany punkt odniesienia do oceny i postępowania w przypadku SVT, w tym trzepotania przedsionków75.

Ogólne rokowanie

SVT generalnie nie zagraża życiu, a rokowanie jest zwykle dobre przy braku strukturalnej choroby serca76. Wielu bezobjawowych pacjentów nie potrzebuje leczenia SVT i ma generalnie łagodny przebieg choroby77.

Pacjenci z cięższymi objawami lub współistniejącą chorobą serca mogą wymagać wcześniejszej interwencji terapeutycznej w ostrej fazie i długoterminowego postępowania78. Rzadko SVT może powodować nagłą śmierć sercową79.

Z czasem nieleczone i częste ataki tachykardii nadkomorowej mogą osłabić serce i prowadzić do niewydolności serca80. Poważny atak SVT może spowodować omdlenie lub nawet nagłe zatrzymanie czynności serca81.

Podejścia do długoterminowego zarządzania

Długoterminowe postępowanie jest zindywidualizowane na podstawie częstości i ciężkości epizodów oraz wpływu objawów na jakość życia82. Po ustąpieniu ostrej arytmii, może być wskazane leczenie ciągłe, aby zapobiec nawrotom. Jednak pacjenci, którzy mają izolowany epizod lub rzadkie i minimalnie objawowe epizody, zwykle nie wymagają leczenia innego niż obserwacja i wyjaśnienie83.

Ablacja radioczęstotliwościowa zrewolucjonizowała leczenie tachykardii spowodowanej drogą nawrotową. Jest to procedura o niskim ryzyku, która wykorzystuje cewnik wewnątrz serca do dostarczenia energii radiowej w celu zlokalizowania i zniszczenia nieprawidłowych dróg elektrycznych. Ablacja wykazała się wysoką skutecznością: około 90% w przypadku AVNRT. Podobne wysokie wskaźniki powodzenia osiągane są w przypadku AVRT i typowego trzepotania przedsionków84.

Wskaźniki powodzenia po ablacji cewnikowej u pacjentów z ACHD są nieco niższe w porównaniu z populacją ogólną, z ostrymi i długoterminowymi wskaźnikami powodzenia wynoszącymi odpowiednio 80% i 68% dla ablacji drogi dodatkowej oraz 66-76% i 50-53% dla makroarentrantnych częstoskurczów przedsionkowych85.

Ablacja cewnikowa jest zalecana dla większości pacjentów z nawracającymi objawowymi epizodami SVT, które wpływają na ich jakość życia. Ma niskie ryzyko powikłań i jest skuteczna u ponad 95% pacjentów86. Procedura ta jest bardzo skuteczna u większości pacjentów – ponad 95% pacjentów poddanych ablacji cewnikowej w przypadku SVT zostaje wyleczonych87.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Supraventricular tachycardia: An overview of diagnosis and management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6964177/
    Supraventricular tachycardia (SVT) is a common cause of hospital admissions and can cause significant patient discomfort and distress. The prevalence of SVT is 2.25/1000 persons with a female predominance of 2:1 across all age groups. SVT increases patient morbidity, particularly when symptoms are frequent or incessant, and in a small cohort of patients with atrial fibrillation (AF) and ventricular pre-excitation, it can be life-threatening. […] Long-term management is contingent on the underlying mechanism, frequency of symptoms, patient safety and preference. However, the potential for substantial improvements in quality of life, reduced hospital attendances and cost burden make catheter ablation a particularly desirable option as first line therapy for all SVTs, especially in AVNRT and AVRT where documented cure rates can exceed 95% with an associated risk of 1% for major complications. […] Supraventricular tachycardia is a common cause of hospital attendance and acute admission.
  • #2 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #3 Common Types of Supraventricular Tachycardia: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2010/1015/p942.html
    A more recent article on common types of supraventricular tachycardia is available. […] The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. […] SVTs (excluding atrial fibrillation or flutter and multifocal AT) have an estimated incidence of 35 per 100,000 person-years, with a prevalence of 2.29 per 1,000 persons. […] Although AVNRT is the most common SVT in adults (approximately 50 to 60 percent), AVRT is most common in children (accounts for approximately 30 percent of all SVTs).
  • #4 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #5 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    The incidence of paroxysmal SVT is approximately 36 per 100,000 persons. […] Atrial fibrillation is the most common, affecting 3 million people in the United States alone, with prevalence of 0.4-1% in the population. It is estimated that atrial fibrillation will affect more than 7.5 million people by 2050. […] In a population-based study, the incidence of paroxysmal SVT was 35 cases per 100,000 person-years and peak incidence was in the middle age people. […] AVNRT is more common in patients who are middle-aged or older, while adolescents are more likely to have SVT mediated by an accessory pathway like AVRT. […] The incidence rate of the WPW pattern on ECG tracings is 0.1-0.3% in the general population, although not all patients develop SVT. […] Paroxysmal SVT is observed not only in healthy individuals; it is also common in patients with previous myocardial infarction, mitral valve prolapse, rheumatic heart disease, pericarditis, pneumonia, chronic lung disease, and current alcohol intoxication.
  • #6 Supraventricular tachycardia | The Medical Journal of Australia
    https://www.mja.com.au/journal/2009/190/5/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. […] The incidence of SVT is about 35 cases per 100 000 population per year, with a prevalence of 2.25 cases per 1000 population. […] For the three most common types of SVT, peak incidence of presentation for ablation occurs in the middle decades of life: at 36 years for AVRT, 48 years for AVNRT, and 50 years for AT. […] A significant proportion of patients have symptoms for a prolonged period ( 1 year) before the diagnosis of SVT is made, and occasionally episodes are misdiagnosed as anxiety or panic disorders. […] Long-term management is individualised based on the frequency and severity of episodes and the impact of symptoms on quality of life. […] Definitive treatment of SVT is indicated in patients who have recurrent symptomatic episodes of SVT that affect their quality of life. […] Radiofrequency catheter ablation is recommended for most of these patients. It has a low risk of complications, and is curative in more than 95% of patients.
  • #7 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #8 PSVT – Areas of Focus – Milestone Pharma
    https://milestonepharma.com/areas-of-focus/paroxysmal-supraventricular-tachycardia-psvt/?lang=en-cn
    PSVT affects approximately two million Americans and results in as many as 300,000 new diagnoses and over 600,000 healthcare claims in the U.S. per year, including emergency department visits, hospital admissions, and ablations. […] A 2021 retrospective, observational, longitudinal analysis published in the Journal of Cardiovascular Electrophysiology utilized claims data from both Medicare and private insurers to estimate the treated prevalence and incidence of PSVT in the U.S. over a nine-year period (2008–2016). This study found that the U.S. treated prevalence for PSVT was 1.3–2.1 million, with approximately 190,000–310,000 new cases each year. […] Compared to past analyses, the updated PSVT prevalence and incidence data show more than twofold increases. […] This retrospective, observational, longitudinal analysis—which accounted for misdiagnoses and overlap with symptoms of AFib/AFL—generated a more definitive, updated treated prevalence estimate for PSVT within the U.S. population.
  • #9 PSVT – Areas of Focus – Milestone Pharma
    https://milestonepharma.com/areas-of-focus/paroxysmal-supraventricular-tachycardia-psvt/?lang=en-cn
    PSVT affects approximately two million Americans and results in as many as 300,000 new diagnoses and over 600,000 healthcare claims in the U.S. per year, including emergency department visits, hospital admissions, and ablations. […] A 2021 retrospective, observational, longitudinal analysis published in the Journal of Cardiovascular Electrophysiology utilized claims data from both Medicare and private insurers to estimate the treated prevalence and incidence of PSVT in the U.S. over a nine-year period (2008–2016). This study found that the U.S. treated prevalence for PSVT was 1.3–2.1 million, with approximately 190,000–310,000 new cases each year. […] Compared to past analyses, the updated PSVT prevalence and incidence data show more than twofold increases. […] This retrospective, observational, longitudinal analysis—which accounted for misdiagnoses and overlap with symptoms of AFib/AFL—generated a more definitive, updated treated prevalence estimate for PSVT within the U.S. population.
  • #10 Supraventricular tachycardia: An overview of diagnosis and management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6964177/
    Supraventricular tachycardia (SVT) is a common cause of hospital admissions and can cause significant patient discomfort and distress. The prevalence of SVT is 2.25/1000 persons with a female predominance of 2:1 across all age groups. SVT increases patient morbidity, particularly when symptoms are frequent or incessant, and in a small cohort of patients with atrial fibrillation (AF) and ventricular pre-excitation, it can be life-threatening. […] Long-term management is contingent on the underlying mechanism, frequency of symptoms, patient safety and preference. However, the potential for substantial improvements in quality of life, reduced hospital attendances and cost burden make catheter ablation a particularly desirable option as first line therapy for all SVTs, especially in AVNRT and AVRT where documented cure rates can exceed 95% with an associated risk of 1% for major complications. […] Supraventricular tachycardia is a common cause of hospital attendance and acute admission.
  • #11 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #12 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #13 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    Most series of catheter ablation reflect a higher proportion of female patients with AVNRT than male patients. […] In a population-based study, the risk of developing paroxysmal SVT was twice as high in women as it was in men. […] The prevalence of paroxysmal SVT increases with age, with an estimated 5-fold likelihood of affecting older people than younger ones. […] AVNRT is seen more commonly in persons who are middle aged or older, while adolescents usually have SVT from an accessory pathway. […] The relative frequency of tachycardia mediated by an accessory pathway decreases with age.
  • #14 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #15 Supraventricular Tachycardia (SVT) • LITFL • ECG Library Diagnosis
    https://litfl.com/supraventricular-tachycardia-svt-ecg-library/
    The term supraventricular tachycardia (SVT) refers to any tachydysrhythmia arising from above the level of the Bundle of His, and encompasses regular atrial, irregular atrial, and regular atrioventricular tachycardias. […] AVNRT is typically paroxysmal and may occur spontaneously or upon provocation with exertion, caffeine, alcohol, beta-agonists (salbutamol) or sympathomimetics (amphetamines). […] It is more common in women than men (~ 75% of cases occurring in women) and may occur in young and healthy patients as well as those suffering chronic heart disease. […] The condition is generally well tolerated and is rarely life threatening in patients with pre-existing heart disease. […] Most other types of SVT are discussed elsewhere (follow links in classification table).
  • #16 Diagnosis and Management of Common Types of Supraventricular Tachycardia | AAFP
    https://www.aafp.org/pubs/afp/issues/2015/1101/p793.html
    Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The overall prevalence of SVT is two or three per 1,000 persons in the general population. The mean age of occurrence is 45 years, and 62% of cases occur in women. AVNRT is the most common type of SVT in adults. SVT occurs in one per 250 to 1,000 infants and children, with AVRT accounting for most cases. […] The incidence of AVNRT in women is twice that in men. It is correlated with lower estrogen levels and higher progesterone levels, and is therefore more common during the luteal phase of the menstrual cycle and less common during pregnancy. AVNRT involves a pattern of reentry in persons who have two pathways in their atrioventricular (AV) node, one slow and one fast. […] The second most common type of SVT is AVRT. There is a progressive decline in the proportion of SVT caused by AVRT as age increases, from 60% in the first decade of life to 9% after 70 years of age.
  • #17 Supraventricular tachycardia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243
    Supraventricular tachycardia (SVT) is the most common type of arrhythmia in infants and children. […] Supraventricular tachycardia (SVT) also tends to occur more often in women, particularly during pregnancy. […] Health conditions or treatments that may increase the risk of supraventricular tachycardia include coronary artery disease, heart valve disease and other heart diseases. […] Over time, untreated and frequent attacks of supraventricular tachycardia (SVT) may weaken the heart and lead to heart failure. […] A severe attack of SVT may cause fainting or a sudden loss of all heart activity, called sudden cardiac arrest.
  • #18 Supraventricular Tachycardia (SVT): Types, Causes, & Risk Factors
    https://www.webmd.com/heart-disease/atrial-fibrillation/what-is-supraventricular-tachycardia
    SVT usually affects younger people. It often starts when you’re in your teens or early 20s. But young children, middle-aged people, or older people can also have SVT. SVT is more common in women or those assigned female at birth, especially during pregnancy. […] You’re at a high risk of some types of SVT if you’re middle-aged or older and when you’re pregnant. […] Several health conditions raise your risk, including: Heart disease (coronary artery disease, heart failure, disease of the heart muscle or valve), Lung disease, Thyroid disease, Diabetes, Sleep apnea. […] SVT is usually caused by things you can’t control, such as a medical condition or previous surgery. Sometimes, an episode is triggered by stress, exercise, or lack of sleep, though it usually happens without any obvious reason.
  • #19 Supraventricular Tachycardia (SVT): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/22152-svt-supraventricular-tachycardia
    SVT (supraventricular tachycardia) is a common kind of arrhythmia (abnormal heart rhythm). […] SVT is an abnormal heart rhythm thats very fast and starts in the upper part of your heart. Various types of SVT all have a fast heart rate and start in your hearts upper chambers. […] Supraventricular tachycardia (SVT) is a fast heart rate that starts in your upper heart chambers. […] A problem with your hearts electrical signals or circuitry causes SVT. […] Children and adults can get supraventricular tachycardia. Risk factors for SVT include: Being female. […] A serious case of SVT may lead to: Heart failure. […] SVT isnt life-threatening in most cases, but it can be for people with other heart issues. […] The outlook is good for most people with SVT. […] Yes. You can manage very infrequent episodes with medications.
  • #20 Atrioventricular Nodal Reentry Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/160215-overview
    In the United States, atrioventricular nodal reentry tachycardia (AVNRT) occurs in 60% of patients (with a female predominance) presenting with paroxysmal supraventricular tachycardia (SVT), the other major types being bypass-mediated tachycardias and atrial tachycardias. SVT has a prevalence of 2.25 cases per 1000 in the general population and an incidence of 35 per 100,000 patients. Internationally, the occurrence of AVNRT is similar to that in the United States. […] AVNRT may occur in persons of any age. It is common in young adults, but some patients do not present until their seventh or eighth decade or later.
  • #21 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #22 Diagnosis and Management of Common Types of Supraventricular Tachycardia | AAFP
    https://www.aafp.org/pubs/afp/issues/2015/1101/p793.html
    Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The overall prevalence of SVT is two or three per 1,000 persons in the general population. The mean age of occurrence is 45 years, and 62% of cases occur in women. AVNRT is the most common type of SVT in adults. SVT occurs in one per 250 to 1,000 infants and children, with AVRT accounting for most cases. […] The incidence of AVNRT in women is twice that in men. It is correlated with lower estrogen levels and higher progesterone levels, and is therefore more common during the luteal phase of the menstrual cycle and less common during pregnancy. AVNRT involves a pattern of reentry in persons who have two pathways in their atrioventricular (AV) node, one slow and one fast. […] The second most common type of SVT is AVRT. There is a progressive decline in the proportion of SVT caused by AVRT as age increases, from 60% in the first decade of life to 9% after 70 years of age.
  • #23 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    Most series of catheter ablation reflect a higher proportion of female patients with AVNRT than male patients. […] In a population-based study, the risk of developing paroxysmal SVT was twice as high in women as it was in men. […] The prevalence of paroxysmal SVT increases with age, with an estimated 5-fold likelihood of affecting older people than younger ones. […] AVNRT is seen more commonly in persons who are middle aged or older, while adolescents usually have SVT from an accessory pathway. […] The relative frequency of tachycardia mediated by an accessory pathway decreases with age.
  • #24 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #25 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #26 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #27 Supraventricular tachycardia | The Medical Journal of Australia
    https://www.mja.com.au/journal/2009/190/5/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. […] The incidence of SVT is about 35 cases per 100 000 population per year, with a prevalence of 2.25 cases per 1000 population. […] For the three most common types of SVT, peak incidence of presentation for ablation occurs in the middle decades of life: at 36 years for AVRT, 48 years for AVNRT, and 50 years for AT. […] A significant proportion of patients have symptoms for a prolonged period ( 1 year) before the diagnosis of SVT is made, and occasionally episodes are misdiagnosed as anxiety or panic disorders. […] Long-term management is individualised based on the frequency and severity of episodes and the impact of symptoms on quality of life. […] Definitive treatment of SVT is indicated in patients who have recurrent symptomatic episodes of SVT that affect their quality of life. […] Radiofrequency catheter ablation is recommended for most of these patients. It has a low risk of complications, and is curative in more than 95% of patients.
  • #28 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #29 Supraventricular tachycardia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243
    Supraventricular tachycardia (SVT) is the most common type of arrhythmia in infants and children. […] Supraventricular tachycardia (SVT) also tends to occur more often in women, particularly during pregnancy. […] Health conditions or treatments that may increase the risk of supraventricular tachycardia include coronary artery disease, heart valve disease and other heart diseases. […] Over time, untreated and frequent attacks of supraventricular tachycardia (SVT) may weaken the heart and lead to heart failure. […] A severe attack of SVT may cause fainting or a sudden loss of all heart activity, called sudden cardiac arrest.
  • #30 Supraventricular Tachycardia | Select 5-Minute Pediatrics Topics
    https://www.unboundmedicine.com/5minute/view/Select-5-Minute-Pediatric-Consult/14069/all/Supraventricular_Tachycardia
    SVT is the most common arrhythmia in childhood. […] Incidence of SVT is 35 per 100,000 per year. […] Prevalence of SVT is 1 in 250 to 25,000 children. […] AVRT is the most common type of SVT in children, occurring in ~75% of cases. […] AVNRT rarely occurs before age 2 years. […] 5060% of pediatric patients with SVT present in the 1st year of life.
  • #31 Diagnosis and Management of Common Types of Supraventricular Tachycardia | AAFP
    https://www.aafp.org/pubs/afp/issues/2015/1101/p793.html
    Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The overall prevalence of SVT is two or three per 1,000 persons in the general population. The mean age of occurrence is 45 years, and 62% of cases occur in women. AVNRT is the most common type of SVT in adults. SVT occurs in one per 250 to 1,000 infants and children, with AVRT accounting for most cases. […] The incidence of AVNRT in women is twice that in men. It is correlated with lower estrogen levels and higher progesterone levels, and is therefore more common during the luteal phase of the menstrual cycle and less common during pregnancy. AVNRT involves a pattern of reentry in persons who have two pathways in their atrioventricular (AV) node, one slow and one fast. […] The second most common type of SVT is AVRT. There is a progressive decline in the proportion of SVT caused by AVRT as age increases, from 60% in the first decade of life to 9% after 70 years of age.
  • #32 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #33 Supraventricular Tachycardia SVT
    https://www.rch.org.au/clinicalguide/guideline_index/supraventricular_tachycardia_svt/
    Supraventricular tachycardia (SVT) is common in infancy and childhood. Most SVT in children is due to a re-entrant mechanism and usually occurs in otherwise normally well children […] Greater than a third of new onset SVT occurs in the first few weeks of life, commonly presenting after many hours with signs of heart failure […] SVT is an abnormally fast heart rate originating from above the ventricles […] SVT is one cause of narrow complex tachycardia […] Factors that may contribute to tachycardia (eg sepsis, pain, dehydration, anxiety, and fever) should also be considered and addressed when managing a patient presenting with a tachyarrhythmia […] The child with the following often requires admission: first presentation, under 3 months of age, in heart failure, requiring DC conversion
  • #34 Supraventricular Tachycardia | Select 5-Minute Pediatrics Topics
    https://www.unboundmedicine.com/5minute/view/Select-5-Minute-Pediatric-Consult/14069/all/Supraventricular_Tachycardia
    SVT is the most common arrhythmia in childhood. […] Incidence of SVT is 35 per 100,000 per year. […] Prevalence of SVT is 1 in 250 to 25,000 children. […] AVRT is the most common type of SVT in children, occurring in ~75% of cases. […] AVNRT rarely occurs before age 2 years. […] 5060% of pediatric patients with SVT present in the 1st year of life.
  • #35 Supraventricular Tachycardia | Select 5-Minute Pediatrics Topics
    https://www.unboundmedicine.com/5minute/view/Select-5-Minute-Pediatric-Consult/14069/all/Supraventricular_Tachycardia
    SVT is the most common arrhythmia in childhood. […] Incidence of SVT is 35 per 100,000 per year. […] Prevalence of SVT is 1 in 250 to 25,000 children. […] AVRT is the most common type of SVT in children, occurring in ~75% of cases. […] AVNRT rarely occurs before age 2 years. […] 5060% of pediatric patients with SVT present in the 1st year of life.
  • #36 Supraventricular Tachycardia | Select 5-Minute Pediatrics Topics
    https://www.unboundmedicine.com/5minute/view/Select-5-Minute-Pediatric-Consult/14069/all/Supraventricular_Tachycardia
    SVT is the most common arrhythmia in childhood. […] Incidence of SVT is 35 per 100,000 per year. […] Prevalence of SVT is 1 in 250 to 25,000 children. […] AVRT is the most common type of SVT in children, occurring in ~75% of cases. […] AVNRT rarely occurs before age 2 years. […] 5060% of pediatric patients with SVT present in the 1st year of life.
  • #37 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #38 Common Types of Supraventricular Tachycardia: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2010/1015/p942.html
    A more recent article on common types of supraventricular tachycardia is available. […] The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. […] SVTs (excluding atrial fibrillation or flutter and multifocal AT) have an estimated incidence of 35 per 100,000 person-years, with a prevalence of 2.29 per 1,000 persons. […] Although AVNRT is the most common SVT in adults (approximately 50 to 60 percent), AVRT is most common in children (accounts for approximately 30 percent of all SVTs).
  • #39 Diagnosis and Management of Common Types of Supraventricular Tachycardia | AAFP
    https://www.aafp.org/pubs/afp/issues/2015/1101/p793.html
    Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The overall prevalence of SVT is two or three per 1,000 persons in the general population. The mean age of occurrence is 45 years, and 62% of cases occur in women. AVNRT is the most common type of SVT in adults. SVT occurs in one per 250 to 1,000 infants and children, with AVRT accounting for most cases. […] The incidence of AVNRT in women is twice that in men. It is correlated with lower estrogen levels and higher progesterone levels, and is therefore more common during the luteal phase of the menstrual cycle and less common during pregnancy. AVNRT involves a pattern of reentry in persons who have two pathways in their atrioventricular (AV) node, one slow and one fast. […] The second most common type of SVT is AVRT. There is a progressive decline in the proportion of SVT caused by AVRT as age increases, from 60% in the first decade of life to 9% after 70 years of age.
  • #40 Living with supraventricular tachycardia: from diagnosis to treatment | Spire Healthcare
    https://www.spirehealthcare.com/health-hub/specialties/heart-health/living-with-supraventricular-tachycardia-from-diagnosis-to-treatment/
    You can develop supraventricular tachycardia (SVT) at any age, in fact, some people are born with the condition. […] SVT actually refers to a group of heart rhythm conditions that all affect the electrical signals of the heart above the ventricles and cause a rapid heart rate. SVT includes atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular re-entrant tachycardia (AVRT) and atrial tachycardia (AT). […] AVNRT is the most common type of SVT, making up around 50-60% of SVT cases. […] AVRT is the second-most common type of SVT and often occurs in people with a congenital disorder called Wolff-Parkinson-White syndrome. […] Getting a diagnosis of SVT can be challenging. […] If you have symptoms of SVT, your doctor may recommend having your heart rhythm recorded using a wearable heart monitor. […] If medication proves unsuccessful or if you prefer to avoid drugs, your doctor may recommend an electrophysiology study followed by catheter ablation. […] This procedure is highly successful in most patients over 95% of patients that undergo catheter ablation for SVT are cured.
  • #41 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    The incidence of paroxysmal SVT is approximately 36 per 100,000 persons. […] Atrial fibrillation is the most common, affecting 3 million people in the United States alone, with prevalence of 0.4-1% in the population. It is estimated that atrial fibrillation will affect more than 7.5 million people by 2050. […] In a population-based study, the incidence of paroxysmal SVT was 35 cases per 100,000 person-years and peak incidence was in the middle age people. […] AVNRT is more common in patients who are middle-aged or older, while adolescents are more likely to have SVT mediated by an accessory pathway like AVRT. […] The incidence rate of the WPW pattern on ECG tracings is 0.1-0.3% in the general population, although not all patients develop SVT. […] Paroxysmal SVT is observed not only in healthy individuals; it is also common in patients with previous myocardial infarction, mitral valve prolapse, rheumatic heart disease, pericarditis, pneumonia, chronic lung disease, and current alcohol intoxication.
  • #42 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    Most series of catheter ablation reflect a higher proportion of female patients with AVNRT than male patients. […] In a population-based study, the risk of developing paroxysmal SVT was twice as high in women as it was in men. […] The prevalence of paroxysmal SVT increases with age, with an estimated 5-fold likelihood of affecting older people than younger ones. […] AVNRT is seen more commonly in persons who are middle aged or older, while adolescents usually have SVT from an accessory pathway. […] The relative frequency of tachycardia mediated by an accessory pathway decreases with age.
  • #43 Common Types of Supraventricular Tachycardia: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2010/1015/p942.html
    A more recent article on common types of supraventricular tachycardia is available. […] The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. […] SVTs (excluding atrial fibrillation or flutter and multifocal AT) have an estimated incidence of 35 per 100,000 person-years, with a prevalence of 2.29 per 1,000 persons. […] Although AVNRT is the most common SVT in adults (approximately 50 to 60 percent), AVRT is most common in children (accounts for approximately 30 percent of all SVTs).
  • #44 Common Types of Supraventricular Tachycardia: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2010/1015/p942.html
    A more recent article on common types of supraventricular tachycardia is available. […] The most common types of supraventricular tachycardia are caused by a reentry phenomenon producing accelerated heart rates. […] SVTs (excluding atrial fibrillation or flutter and multifocal AT) have an estimated incidence of 35 per 100,000 person-years, with a prevalence of 2.29 per 1,000 persons. […] Although AVNRT is the most common SVT in adults (approximately 50 to 60 percent), AVRT is most common in children (accounts for approximately 30 percent of all SVTs).
  • #45 Diagnosis and Management of Common Types of Supraventricular Tachycardia | AAFP
    https://www.aafp.org/pubs/afp/issues/2015/1101/p793.html
    Supraventricular tachycardia refers to rapid rhythms that originate and are sustained in atrial or atrioventricular node tissue above the bundle of His. The overall prevalence of SVT is two or three per 1,000 persons in the general population. The mean age of occurrence is 45 years, and 62% of cases occur in women. AVNRT is the most common type of SVT in adults. SVT occurs in one per 250 to 1,000 infants and children, with AVRT accounting for most cases. […] The incidence of AVNRT in women is twice that in men. It is correlated with lower estrogen levels and higher progesterone levels, and is therefore more common during the luteal phase of the menstrual cycle and less common during pregnancy. AVNRT involves a pattern of reentry in persons who have two pathways in their atrioventricular (AV) node, one slow and one fast. […] The second most common type of SVT is AVRT. There is a progressive decline in the proportion of SVT caused by AVRT as age increases, from 60% in the first decade of life to 9% after 70 years of age.
  • #46 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    Most series of catheter ablation reflect a higher proportion of female patients with AVNRT than male patients. […] In a population-based study, the risk of developing paroxysmal SVT was twice as high in women as it was in men. […] The prevalence of paroxysmal SVT increases with age, with an estimated 5-fold likelihood of affecting older people than younger ones. […] AVNRT is seen more commonly in persons who are middle aged or older, while adolescents usually have SVT from an accessory pathway. […] The relative frequency of tachycardia mediated by an accessory pathway decreases with age.
  • #47 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    The incidence of paroxysmal SVT is approximately 36 per 100,000 persons. […] Atrial fibrillation is the most common, affecting 3 million people in the United States alone, with prevalence of 0.4-1% in the population. It is estimated that atrial fibrillation will affect more than 7.5 million people by 2050. […] In a population-based study, the incidence of paroxysmal SVT was 35 cases per 100,000 person-years and peak incidence was in the middle age people. […] AVNRT is more common in patients who are middle-aged or older, while adolescents are more likely to have SVT mediated by an accessory pathway like AVRT. […] The incidence rate of the WPW pattern on ECG tracings is 0.1-0.3% in the general population, although not all patients develop SVT. […] Paroxysmal SVT is observed not only in healthy individuals; it is also common in patients with previous myocardial infarction, mitral valve prolapse, rheumatic heart disease, pericarditis, pneumonia, chronic lung disease, and current alcohol intoxication.
  • #48 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #49 Optimal SVT management: Are we there? – Professional Heart Daily | American Heart Association
    https://professional.heart.org/en/science-news/guideline-for-the-management-of-adult-patients-with-supraventricular-tachycardia/Commentary
    While not provoking the same clinical challenge of ventricular tachyarrhythmias and sudden cardiac arrest, nevertheless SVTs have a considerable prevalence in the general population of 2.25 per 1,000 persons. […] Often initially presenting to emergency departments with palpitations, patients with SVT due to atrioventricular reentrant tachycardia (AVRT) using an accessory pathway have a younger mean age at onset than patients with atrioventricular nodal reentrant tachycardia (AVNRT). […] Women more than men have AVNRT, while more men may have AVRT. […] The incidence of manifest WPW pattern on the ECG is 0.1-0.3% in the general population, while the frequency of AVRT decreases with age. […] More than half of the SVT episodes occur during driving, and the episodes are an obstacle in one-fourth.
  • #50 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #51 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #52 Supraventricular Tachycardia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK441972/
    Atrioventricular nodal reentrant tachycardia has an incidence of 35 per 10,000 person-years, or 2.29 per 1000 individuals, making it the most common tachyarrhythmia among young adults. Women are at a 2-fold higher risk of developing paroxysmal supraventricular tachycardia compared to men, whereas older individuals have a 5-fold increased risk compared to younger individuals. […] Supraventricular tachycardia is the most common symptomatic arrhythmia in infants and children. Children with congenital heart diseases, such as the Ebstein anomaly of the tricuspid valve, are at higher risk for atrioventricular reciprocating tachycardia. In addition, young adults who have undergone Fontan surgery or surgery for tetralogy of Fallot are at an increased risk for atrial arrhythmias. In children younger than 12, an accessory atrioventricular pathway causing reentrant tachycardia is the most prevalent cause of supraventricular tachycardia.
  • #53 Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease | AER Journal
    https://www.aerjournal.com/articles/supraventricular-arrhythmias-patients-adult-congenital-heart-disease
    An increasing number of patients with congenital heart disease survive to adulthood; such prolonged survival is related to a rapid evolution of successful surgical repairs and modern diagnostic techniques. […] Macroreentrant atrial tachycardias are the most common (75 %) type of supraventricular tachycardia (SVT) in patients with adult congenital heart disease (ACHD). […] The 20-year risk of developing atrial arrhythmias among patients with adult congenital heart disease (ACHD) was 7 % in a patient aged 20 years and 38 % in a patient aged 50 years in a population-based study. […] MRATs are the most common type of supraventricular tachycardia (SVT) in patients with ACHD, occurring in 75 % of ACHD-associated SVT cases, most commonly in patients with Ebsteins anomaly, Tetralogy of Fallot, single-ventricle Fontan procedures, transposition of the great arteries (TGA) or atrial septal defects (ASDs).
  • #54 Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease | AER Journal
    https://www.aerjournal.com/articles/supraventricular-arrhythmias-patients-adult-congenital-heart-disease
    An increasing number of patients with congenital heart disease survive to adulthood; such prolonged survival is related to a rapid evolution of successful surgical repairs and modern diagnostic techniques. […] Macroreentrant atrial tachycardias are the most common (75 %) type of supraventricular tachycardia (SVT) in patients with adult congenital heart disease (ACHD). […] The 20-year risk of developing atrial arrhythmias among patients with adult congenital heart disease (ACHD) was 7 % in a patient aged 20 years and 38 % in a patient aged 50 years in a population-based study. […] MRATs are the most common type of supraventricular tachycardia (SVT) in patients with ACHD, occurring in 75 % of ACHD-associated SVT cases, most commonly in patients with Ebsteins anomaly, Tetralogy of Fallot, single-ventricle Fontan procedures, transposition of the great arteries (TGA) or atrial septal defects (ASDs).
  • #55 Paroxysmal Supraventricular Tachycardia: Background, Etiology, Epidemiology
    https://emedicine.medscape.com/article/156670-overview
    The incidence of paroxysmal SVT is approximately 36 per 100,000 persons. […] Atrial fibrillation is the most common, affecting 3 million people in the United States alone, with prevalence of 0.4-1% in the population. It is estimated that atrial fibrillation will affect more than 7.5 million people by 2050. […] In a population-based study, the incidence of paroxysmal SVT was 35 cases per 100,000 person-years and peak incidence was in the middle age people. […] AVNRT is more common in patients who are middle-aged or older, while adolescents are more likely to have SVT mediated by an accessory pathway like AVRT. […] The incidence rate of the WPW pattern on ECG tracings is 0.1-0.3% in the general population, although not all patients develop SVT. […] Paroxysmal SVT is observed not only in healthy individuals; it is also common in patients with previous myocardial infarction, mitral valve prolapse, rheumatic heart disease, pericarditis, pneumonia, chronic lung disease, and current alcohol intoxication.
  • #56 Supraventricular Tachycardia: Symptoms & Causes | NewYork-Presbyterian
    https://www.nyp.org/heart/arrhythmias/supraventricular-tachycardia-svt
    Symptoms of SVT in babies are subtle and often involve poor feeding, vomiting, or a decrease in the alertness and activity levels of the baby. Symptoms of supraventricular tachycardia causes include: Heart disease, Heart conditions present at birth, such as Wolff-Parkinson-White syndrome, Lung disease, Thyroid disease, Pregnancy, Certain medications, Excess caffeine, Excess alcohol, Drug use (for example, cocaine and methamphetamine), Smoking. […] Risk factors for supraventricular tachycardia are: Age – Certain types of SVT are more common in older people, Heart disease – Coronary artery disease and other heart diseases, Congenital heart disease – Heart condition that is present at birth and is typically diagnosed in children or young adults, Thyroid disease – Patients with hyperactive (overactive) thyroid glands often have supraventricular tachycardia, Diabetes – Increases the risk of heart disease and supraventricular tachycardia, Obstructive sleep apnea, Smoking, Illegal drug use.
  • #57 Supraventricular Tachycardia (SVT): Types, Causes, & Risk Factors
    https://www.webmd.com/heart-disease/atrial-fibrillation/what-is-supraventricular-tachycardia
    SVT usually affects younger people. It often starts when you’re in your teens or early 20s. But young children, middle-aged people, or older people can also have SVT. SVT is more common in women or those assigned female at birth, especially during pregnancy. […] You’re at a high risk of some types of SVT if you’re middle-aged or older and when you’re pregnant. […] Several health conditions raise your risk, including: Heart disease (coronary artery disease, heart failure, disease of the heart muscle or valve), Lung disease, Thyroid disease, Diabetes, Sleep apnea. […] SVT is usually caused by things you can’t control, such as a medical condition or previous surgery. Sometimes, an episode is triggered by stress, exercise, or lack of sleep, though it usually happens without any obvious reason.
  • #58 Supraventricular tachycardia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243
    Supraventricular tachycardia (SVT) is the most common type of arrhythmia in infants and children. […] Supraventricular tachycardia (SVT) also tends to occur more often in women, particularly during pregnancy. […] Health conditions or treatments that may increase the risk of supraventricular tachycardia include coronary artery disease, heart valve disease and other heart diseases. […] Over time, untreated and frequent attacks of supraventricular tachycardia (SVT) may weaken the heart and lead to heart failure. […] A severe attack of SVT may cause fainting or a sudden loss of all heart activity, called sudden cardiac arrest.
  • #59 Supraventricular Tachycardia (SVT) – Melbourne Heart Rhythm
    https://www.melbourneheartrhythm.com.au/learn/conditions/76-supraventricular-tachycardia-svt
    What is a Supraventricular Tachycardia? In some hearts, an abnormal heart rhythm develops in the top part of the heart when an electrical impulse either starts from a different location other than the SA node, or follows a route (or pathway) that is not normally present. When this occurs the heart will suddenly start racing. The heart rate is usually over 150 beats per minute and often over 200 beats per minute. Certain things in some people can trigger episodes. These include caffeine, alcohol, anxiety, exercise or sudden movements such as bending over. However, often these episodes can occur at any time without a trigger. During an episode, you will usually be aware of the rapid beating of your heart. […] In the vast majority of cases SVT is a benign condition. This means that it will not cause sudden death, will not damage the heart or cause a heart attack and will not shorten life expectancy. There are some rare exceptions that will be discussed with you if relevant. […] There are 3 main types of SVT. It will not always be obvious which type of SVT you have prior to the electrical study of your heart. […] There are 3 main options for people with SVT.
  • #60 Supraventricular Tachycardia (SVT) • LITFL • ECG Library Diagnosis
    https://litfl.com/supraventricular-tachycardia-svt-ecg-library/
    The term supraventricular tachycardia (SVT) refers to any tachydysrhythmia arising from above the level of the Bundle of His, and encompasses regular atrial, irregular atrial, and regular atrioventricular tachycardias. […] AVNRT is typically paroxysmal and may occur spontaneously or upon provocation with exertion, caffeine, alcohol, beta-agonists (salbutamol) or sympathomimetics (amphetamines). […] It is more common in women than men (~ 75% of cases occurring in women) and may occur in young and healthy patients as well as those suffering chronic heart disease. […] The condition is generally well tolerated and is rarely life threatening in patients with pre-existing heart disease. […] Most other types of SVT are discussed elsewhere (follow links in classification table).
  • #61 PSVT – Areas of Focus – Milestone Pharma
    https://milestonepharma.com/areas-of-focus/paroxysmal-supraventricular-tachycardia-psvt/?lang=en-cn
    Current treatment for PSVT consumes significant healthcare resources. […] Based on market data on file, we estimate approximately 80,000 catheter ablations and more than 150,000 ED visits/hospital admissions for PSVT occur each year, driving the majority of the approximately $3 billion spent annually in the U.S. on the management of PSVT. […] This study followed patients for up to six years post-diagnosis. Similar to the American Journal of Cardiology study, this data showed that costs never return to baseline, which indicates a need for more treatment options in long-term PSVT management.
  • #62 PSVT – Areas of Focus – Milestone Pharma
    https://milestonepharma.com/areas-of-focus/paroxysmal-supraventricular-tachycardia-psvt/?lang=en-cn
    Current treatment for PSVT consumes significant healthcare resources. […] Based on market data on file, we estimate approximately 80,000 catheter ablations and more than 150,000 ED visits/hospital admissions for PSVT occur each year, driving the majority of the approximately $3 billion spent annually in the U.S. on the management of PSVT. […] This study followed patients for up to six years post-diagnosis. Similar to the American Journal of Cardiology study, this data showed that costs never return to baseline, which indicates a need for more treatment options in long-term PSVT management.
  • #63 Supraventricular tachycardia | The Medical Journal of Australia
    https://www.mja.com.au/journal/2009/190/5/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. […] The incidence of SVT is about 35 cases per 100 000 population per year, with a prevalence of 2.25 cases per 1000 population. […] For the three most common types of SVT, peak incidence of presentation for ablation occurs in the middle decades of life: at 36 years for AVRT, 48 years for AVNRT, and 50 years for AT. […] A significant proportion of patients have symptoms for a prolonged period ( 1 year) before the diagnosis of SVT is made, and occasionally episodes are misdiagnosed as anxiety or panic disorders. […] Long-term management is individualised based on the frequency and severity of episodes and the impact of symptoms on quality of life. […] Definitive treatment of SVT is indicated in patients who have recurrent symptomatic episodes of SVT that affect their quality of life. […] Radiofrequency catheter ablation is recommended for most of these patients. It has a low risk of complications, and is curative in more than 95% of patients.
  • #64 Epidemiological characteristics of patients with supraventricular tachycardias who were inappropriately diagnosed with panic attacks: Experience from a large Saudi tertiary care center
    https://www.j-saudi-heart.com/jsha/vol37/iss1/7/
    Supraventricular tachycardia (SVT) is a significant cause of morbidity in patients visiting cardiology clinics with a chief complaint of palpitations and notable signs of distress worldwide. […] The chances of misdiagnosing patients with panic attacks increase because of the self-terminating nature of SVTs. […] In the final group, 20 patients (42.6%) were misdiagnosed with anxiety/panic attacks before being correctly diagnosed with SVT. […] SVT can be easily misdiagnosed as anxiety due to several factors, including lack of ECG and overlapping symptomatology. […] Overall, physician awareness must be increased to avoid misdiagnosis, which can delay appropriate management of the underlying medical arrhythmia.
  • #65 Epidemiological characteristics of patients with supraventricular tachycardias who were inappropriately diagnosed with panic attacks: Experience from a large Saudi tertiary care center
    https://www.j-saudi-heart.com/jsha/vol37/iss1/7/
    Supraventricular tachycardia (SVT) is a significant cause of morbidity in patients visiting cardiology clinics with a chief complaint of palpitations and notable signs of distress worldwide. […] The chances of misdiagnosing patients with panic attacks increase because of the self-terminating nature of SVTs. […] In the final group, 20 patients (42.6%) were misdiagnosed with anxiety/panic attacks before being correctly diagnosed with SVT. […] SVT can be easily misdiagnosed as anxiety due to several factors, including lack of ECG and overlapping symptomatology. […] Overall, physician awareness must be increased to avoid misdiagnosis, which can delay appropriate management of the underlying medical arrhythmia.
  • #66 Living with supraventricular tachycardia: from diagnosis to treatment | Spire Healthcare
    https://www.spirehealthcare.com/health-hub/specialties/heart-health/living-with-supraventricular-tachycardia-from-diagnosis-to-treatment/
    You can develop supraventricular tachycardia (SVT) at any age, in fact, some people are born with the condition. […] SVT actually refers to a group of heart rhythm conditions that all affect the electrical signals of the heart above the ventricles and cause a rapid heart rate. SVT includes atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular re-entrant tachycardia (AVRT) and atrial tachycardia (AT). […] AVNRT is the most common type of SVT, making up around 50-60% of SVT cases. […] AVRT is the second-most common type of SVT and often occurs in people with a congenital disorder called Wolff-Parkinson-White syndrome. […] Getting a diagnosis of SVT can be challenging. […] If you have symptoms of SVT, your doctor may recommend having your heart rhythm recorded using a wearable heart monitor. […] If medication proves unsuccessful or if you prefer to avoid drugs, your doctor may recommend an electrophysiology study followed by catheter ablation. […] This procedure is highly successful in most patients over 95% of patients that undergo catheter ablation for SVT are cured.
  • #67 Exploring Supraventricular Tachycardia – Professional Heart Daily | American Heart Association
    https://professional.heart.org/en/education/exploring-supraventricular-tachycardia
    In this podcast, we delve into the case of a 50-year-old female experiencing palpitations, chest discomfort, and shortness of breath. We will explore various diagnostic options for patients without previously diagnosed supraventricular tachycardia (SVT), including the use of consumer devices and remote monitoring with medical devices. […] Moderated by Dr. Cicely Dye, this podcast features Dr. Kamala Tamirisa and Dr. Annabelle Santos Volgman as they examine the case of a 22-year-old G1P0 woman with a narrow complex tachycardia. Learn as they discuss the epidemiology of supraventricular tachycardia (SVT) in pregnancy, consider the impact on maternal and fetal outcomes, and explore treatment options during pregnancy and in the peripartum time period.
  • #68 Supraventricular tachycardia | Great Ormond Street Hospital
    https://www.gosh.nhs.uk/conditions-and-treatments/conditions-we-treat/supraventricular-tachycardia/
    Supraventricular tachycardia (SVT) is the name given to the condition where the heart beats extremely fast but in a regular fashion for a period of minutes to hours. […] SVT may be caused by an additional electrical pathway that forms when the baby’s heart is developing in the womb. […] The additional pathway causes episodes where the heart rate suddenly quickens to an abnormally fast rate, often around 200 beats per minute. […] In most cases SVT is diagnosed on an electrocardiogram (ECG) at the time of symptoms of heart racing. […] SVT is confirmed using an ECG, which shows abnormal rhythm during an episode. […] For people with symptoms that are affecting their day to day life, or who have significant episodes, medication can be offered. […] The most effective long term treatment for SVT is cardiac ablation. […] Most episodes of supraventricular tachycardia (SVT) only last for a few minutes and do not need urgent treatment. […] If an episode lasts for a prolonged period, doctors in the AE will try some 'tricks’ to try to slow the heart.
  • #69 Supraventricular Tachycardia: Types, Symptoms, and Treatment
    https://www.healthline.com/health/arrhythmia/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is seen in just over 2 out of every 1,000 people, affecting children and adults alike. […] SVT is caused by the improper functioning of the heart’s electrical system. […] A 2020 study in Clinical Medicine suggests that the use of 12-lead electrocardiography (ECG) is critical in diagnosing SVT and determining short- and long-term management of the condition. […] According to a 2015 study, ablation is considered generally safe and effective for people with recurrent SVT, including children.
  • #70 Supraventricular Tachycardia (SVT) | Deborah Heart & Lung Center
    https://demanddeborah.org/conditions/supraventricular-tachycardia/
    To diagnose supraventricular tachycardia, a physician will test for conditions that may trigger SVT, such as heart disease or a problem with the thyroid gland. The doctor may also perform tests specific to arrhythmia, including: Electrocardiogram (ECG), Holter monitor, Event monitor, Echocardiogram, Implantable loop recorder.
  • #71 Supraventricular Tachycardias: Causes, Symptoms, and Treatment
    https://patient.info/doctor/supraventricular-tachycardia-in-adults
    How common is supraventricular tachycardia? (Epidemiology) The prevalence of SVT is 2.25/1,000 persons and the incidence is 35/100,000 person-years. […] Women have a two times greater risk of developing SVT than men. […] People aged over 65 years have more than five times the risk of developing SVT than younger individuals. […] In a paediatric cohort study of almost 2 million live births between 2000 and 2008, 2,021 patients (51.6% male, overall incidence 1.03/1000) had SVT (Wolff-Parkinson-White (WPW) syndrome accounted for 16.2%). By the age of 15 years, the annual risk of sudden death was 0.01% per patient-year. […] In the general population, the prevalence of a WPW pattern on ECG ranges from 0.15-0.25%, increasing to 0.55% among first-degree relatives of affected patients. However, not all patients develop SVT and intermittent pre-excitation is not rare.
  • #72 Supraventricular Tachycardia (SVT)
    https://www.nationwidechildrens.org/conditions/supraventricular-tachycardia
    Supraventricular tachycardia (soo pruh ven TRIK yuh ler tack ih KAR dee uh), also called SVT, is a very fast heart rhythm that does not follow the regular pathway from the atria to the ventricles. It can cause a heart to beat at rates of 180 to 220 beats per minute in children and up to 300 beats per minute in infants. It can happen at any age and may be your child’s only heart problem. SVT can start and stop quickly. It may last for minutes or continue for hours. If it is not treated, the heart’s ability to pump normally is affected. SVT can occur at rest or be triggered by exercise. There are different types of SVT so your pediatric cardiologist will give more detail on which type of SVT your child has. […] Most children with SVT live completely normal lives and have a normal life expectancy. However, it is important to routinely meet with your child’s pediatric cardiologist for continued SVT care.
  • #73 Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease | AER Journal
    https://www.aerjournal.com/articles/supraventricular-arrhythmias-patients-adult-congenital-heart-disease
    Expert recommendations for physicians managing patients with ACHD is mandatory due to the small number of patients and the potentially life-threatening arrhythmias. […] This review summarises current evidence-based developments in the field, focusing on new advances and general recommendations for the management of patients with ACHD, including published recommendations on management of SVT.
  • #74 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #75 The 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
    https://www.acc.org/latest-in-cardiology/articles/2015/10/08/09/19/the-2015-accahahrs-guideline-for-the-management-of-adult-patients-with-supraventricular-tachycardia
    The guideline begins with a thorough list of definitions and proceeds to a discussion of SVT epidemiology and initial evaluation of the patient with SVT of unknown mechanism. […] Supraventricular tachycardia is a common clinical problem managed by many internists, cardiologists, and electrophysiologists. Despite some of the minor criticisms mentioned above, the new 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients with Supraventricular Tachycardia provides an excellent and comprehensive guide to the management of SVT and is a welcomed update.
  • #76 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #77 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #78 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #79 SVT: Supraventricular Tachycardia – The Cardiology Advisor
    https://www.thecardiologyadvisor.com/ddi/svt-supraventricular-tachycardia/
    The estimated prevalence of SVT is 168 to 332 cases per 100,000 individuals, with female patients constituting 67.5% of cases. Approximately one-half of patients with SVT are age 45 to 64 years. […] SVT is generally not life-threatening, and the prognosis is usually good in the absence of structural heart disease. Many asymptomatic patients do not need SVT treatment and have a generally benign disease course. Patients with more severe symptoms or comorbid heart disease may require earlier acute therapy intervention and long-term management. Rarely, SVT can cause sudden cardiac death. […] Guidelines relevant to the care of patients with SVT include the following: 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia; and 2019 ESC Guidelines for the Management of Patients with Supraventricular Tachycardia.
  • #80 Supraventricular tachycardia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243
    Supraventricular tachycardia (SVT) is the most common type of arrhythmia in infants and children. […] Supraventricular tachycardia (SVT) also tends to occur more often in women, particularly during pregnancy. […] Health conditions or treatments that may increase the risk of supraventricular tachycardia include coronary artery disease, heart valve disease and other heart diseases. […] Over time, untreated and frequent attacks of supraventricular tachycardia (SVT) may weaken the heart and lead to heart failure. […] A severe attack of SVT may cause fainting or a sudden loss of all heart activity, called sudden cardiac arrest.
  • #81 Supraventricular tachycardia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptoms-causes/syc-20355243
    Supraventricular tachycardia (SVT) is the most common type of arrhythmia in infants and children. […] Supraventricular tachycardia (SVT) also tends to occur more often in women, particularly during pregnancy. […] Health conditions or treatments that may increase the risk of supraventricular tachycardia include coronary artery disease, heart valve disease and other heart diseases. […] Over time, untreated and frequent attacks of supraventricular tachycardia (SVT) may weaken the heart and lead to heart failure. […] A severe attack of SVT may cause fainting or a sudden loss of all heart activity, called sudden cardiac arrest.
  • #82 Supraventricular tachycardia | The Medical Journal of Australia
    https://www.mja.com.au/journal/2009/190/5/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. […] The incidence of SVT is about 35 cases per 100 000 population per year, with a prevalence of 2.25 cases per 1000 population. […] For the three most common types of SVT, peak incidence of presentation for ablation occurs in the middle decades of life: at 36 years for AVRT, 48 years for AVNRT, and 50 years for AT. […] A significant proportion of patients have symptoms for a prolonged period ( 1 year) before the diagnosis of SVT is made, and occasionally episodes are misdiagnosed as anxiety or panic disorders. […] Long-term management is individualised based on the frequency and severity of episodes and the impact of symptoms on quality of life. […] Definitive treatment of SVT is indicated in patients who have recurrent symptomatic episodes of SVT that affect their quality of life. […] Radiofrequency catheter ablation is recommended for most of these patients. It has a low risk of complications, and is curative in more than 95% of patients.
  • #83 Supraventricular tachycardia – Wikipedia
    https://en.wikipedia.org/wiki/Supraventricular_tachycardia
    A normal resting heart rate is 60 to 100 beats per minute. A resting heart rate of more than 100 beats per minute is defined as a tachycardia. During an episode of SVT, the heart beats about 150 to 220 times per minute.[9] […] Atrial fibrillation affects about 25 per 1000 people,[7] paroxysmal supraventricular tachycardia 2.3 per 1000,[6] Wolff-Parkinson-White syndrome 2 per 1000,[8] and atrial flutter 0.8 per 1000.[10] […] Once an acute arrhythmia has been terminated, ongoing treatment may be indicated to prevent recurrence. However, those that have an isolated episode, or infrequent and minimally symptomatic episodes, usually do not warrant treatment other than observation and explanation. […] In general, patients with more frequent or disabling symptoms warrant some form of prevention. A variety of drugs including simple AV nodal blocking agents such as beta blockers and verapamil, as well as antiarrhythmic drugs may be used, usually with good effect, although the adverse effects of these therapies need to be weighed against potential benefits.[24]
  • #84 Supraventricular tachycardia – Wikipedia
    https://en.wikipedia.org/wiki/Supraventricular_tachycardia
    Radiofrequency ablation has revolutionized the treatment of tachycardia caused by a re-entrant pathway. This is a low-risk procedure that uses a catheter inside the heart to deliver radiofrequency energy to locate and destroy the abnormal electrical pathways. Ablation has been shown to be highly effective: around 90% in the case of AVNRT. Similar high rates of success are achieved with AVRT and typical atrial flutter.[25] […] This therapy has further improved the treatment options for AVNRT (and other SVTs with pathways close to the AV node), widening the application of curative ablation to young patients with relatively mild but still troublesome symptoms who might not have accepted the risk of requiring a pacemaker.
  • #85 Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease | AER Journal
    https://www.aerjournal.com/articles/supraventricular-arrhythmias-patients-adult-congenital-heart-disease
    Atrial tachycardias (ATs) and impaired ventricular function are thus important and consistent risk factors for SCD in patients with ACHD, of which those with corrected Tetralogy of Fallot, post-atrial switch operation (Mustard or Senning), left heart obstructive lesions and univentricular hearts have the highest risk of SCD (29 % per decade). […] The treatment of CHD imposes certain safety considerations when choosing antiarrhythmic drugs while various cardiac anatomical barriers and required operator expertise should be taken into account when referring patients for catheter ablation. […] The success rates after catheter ablation in patients with ACHD is somewhat lower compared with the general population, with acute and long-term success rates of 80 % and 68 %, respectively, for accessory pathway ablations, and 6676 % and 5053 %, respectively, for MRATs.
  • #86 Supraventricular tachycardia | The Medical Journal of Australia
    https://www.mja.com.au/journal/2009/190/5/supraventricular-tachycardia
    Supraventricular tachycardia (SVT) is a common cardiac rhythm disturbance; it usually presents with recurrent episodes of tachycardia, which often increase in frequency and severity with time. […] The incidence of SVT is about 35 cases per 100 000 population per year, with a prevalence of 2.25 cases per 1000 population. […] For the three most common types of SVT, peak incidence of presentation for ablation occurs in the middle decades of life: at 36 years for AVRT, 48 years for AVNRT, and 50 years for AT. […] A significant proportion of patients have symptoms for a prolonged period ( 1 year) before the diagnosis of SVT is made, and occasionally episodes are misdiagnosed as anxiety or panic disorders. […] Long-term management is individualised based on the frequency and severity of episodes and the impact of symptoms on quality of life. […] Definitive treatment of SVT is indicated in patients who have recurrent symptomatic episodes of SVT that affect their quality of life. […] Radiofrequency catheter ablation is recommended for most of these patients. It has a low risk of complications, and is curative in more than 95% of patients.
  • #87 Living with supraventricular tachycardia: from diagnosis to treatment | Spire Healthcare
    https://www.spirehealthcare.com/health-hub/specialties/heart-health/living-with-supraventricular-tachycardia-from-diagnosis-to-treatment/
    You can develop supraventricular tachycardia (SVT) at any age, in fact, some people are born with the condition. […] SVT actually refers to a group of heart rhythm conditions that all affect the electrical signals of the heart above the ventricles and cause a rapid heart rate. SVT includes atrioventricular nodal re-entrant tachycardia (AVNRT), atrioventricular re-entrant tachycardia (AVRT) and atrial tachycardia (AT). […] AVNRT is the most common type of SVT, making up around 50-60% of SVT cases. […] AVRT is the second-most common type of SVT and often occurs in people with a congenital disorder called Wolff-Parkinson-White syndrome. […] Getting a diagnosis of SVT can be challenging. […] If you have symptoms of SVT, your doctor may recommend having your heart rhythm recorded using a wearable heart monitor. […] If medication proves unsuccessful or if you prefer to avoid drugs, your doctor may recommend an electrophysiology study followed by catheter ablation. […] This procedure is highly successful in most patients over 95% of patients that undergo catheter ablation for SVT are cured.